GoldBamboo.com - Knowledge is strong medicine
  

CHOICE: Communicating Health Options Through Information and Cancer Education - Article


  Not Signed In - Sign In / Register






Colon Polyps

Colonic Polyps; What I need to know about Colon Polyps


Clinical Trial: CHOICE: Communicating Health Options Through Information and Cancer Education

This study is currently recruiting patients.
Verified by Centers for Disease Control and Prevention August 2005

Sponsors and Collaborators: Centers for Disease Control and Prevention
University of North Carolina
Aetna, Inc.
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00134589

Purpose

The purpose of this study is to determine the effectiveness of a two-component intervention that combines academic detailing at the medical practice level and distribution of decision aids at the patient level, on adherence to colorectal cancer screening guidelines.
Condition Intervention Phase
Colorectal Neoplasms
Rectal Neoplasms
Colonic Polyps
 Behavior: Academic Detailing (Med Practices)+Decision Aid (Patients)
Phase IV

MedlinePlus related topics:  Colonic Polyps;   Colorectal Cancer

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study

Official Title: Increasing CRC Screening in Health Plan Members

Further Study Details: 
Primary Outcomes: Completion of colorectal cancer screening
Secondary Outcomes: Patient’s intention to ask/patient asking medical provider for colorectal cancer screening
Expected Total Enrollment:  900

Study start: April 2005;  Expected completion: April 2008

Colorectal cancer is the second most common cause of cancer death in the United States. Early detection and intervention can significantly reduce morbidity and mortality from colorectal cancer (CRC), and current guidelines recommend that asymptomatic adults over age 50 periodically obtain screening by one of several modalities (FOBT, sigmoidoscopy, colonoscopy, or double contrast barium enema). However, CRC screening remains substantially underutilized in the U.S., and more than half of all adults do not adhere to these recommendations. This study was designed to increase CRC screening among health plan members, and involves the collaboration of a major health insurer.

We will conduct a cluster-randomized trial in health practices in Georgia and North Carolina, to test the effectiveness of a decision aid (video + brochures) for increasing adherence to CRC screening guidelines. Thirty large group practices will be recruited and randomized to receive usual care (routine reminders) or an evidence-based decision aid intervention. In each practice, 30 patients between the ages of 52 and 75, without current CRC screening history, will be enrolled into the study. The intervention will continue for up to 2 years for still-unscreened participants. The main outcome will be receipt of an evidence-based modality of CRC screening according to the US Preventive Services Task Force Guidelines (FOBT, flexible sigmoidoscopy, colonoscopy, or double contrast barium enema).

Unique features of the proposed study include its potential to establish systems to increase screening uptake that will help fulfill HEDIS requirements; improving our understanding of how screening promotion interventions work in both White and Black populations; collaboration with a community partner of the Emory Prevention Research Center, and forging collaborative relationships between public health and health care researchers, and the affected communities of health plans and health care providers.

Eligibility

Ages Eligible for Study:  52 Years   -   75 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • Age 52-75
  • Aetna Health Plan Member
  • Average Risk for Colorectal Cancer
  • Did not have colorectal cancer screening within guideline timeframe (1 to 10 years, depending on individual’s age and type of screening)

Exclusion Criteria:

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00134589

Lauren A Taglialatela, MA, PhD      404-727-5575    ltaglia@sph.emory.edu
Karen Glanz, PhD, MPH      404-727-7536    kglanz@sph.emory.edu

Georgia
      Emory University Rollins School of Public Health, Atlanta,  Georgia,  30322,  United States; Recruiting
Lauren A Taglialatela, MA, PhD  404-727-5575    ltaglia@sph.emory.edu 
Karen Glanz, PhD, MPH  404-727-7536    kglanz@sph.emory.edu 
Karen Glanz, PhD, MPH,  Principal Investigator
Tracy Scott, PhD,  Sub-Investigator
Michael Pignone, MD, MPH,  Sub-Investigator
Barbara Rimer, DrPH,  Sub-Investigator

Study chairs or principal investigators

Karen Glanz, PhD, MPH,  Principal Investigator,  Emory University   

More Information

Study ID Numbers:  CDC-NCCDPHP-R-01-PH-000018
Last Updated:  August 24, 2005
Record first received:  August 23, 2005
ClinicalTrials.gov Identifier:  NCT00134589
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-30


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Colon Polyps.

July 26, 2008



Page Updated: September 30, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.